Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2020 Filed May 15, 2020 20:17 UTC |
Heffernan Michael ThomasDirector
|
SaleCommon Stock | 5,905 | $22.64 | $133,689.20 |
DisclosureSEC source: 0001192482-20-000348 · edgar.xml · nonDerivative · entry 3 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,796 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2019. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.02 to $22.98, inclusive. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:17 UTC |
Heffernan Michael ThomasDirector
|
SaleCommon Stock | 11,969 | $21.21 | $253,862.49 |
DisclosureSEC source: 0001192482-20-000348 · edgar.xml · nonDerivative · entry 2 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,701 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2019. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.01 to $22.00, inclusive. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:17 UTC |
Heffernan Michael ThomasDirector
|
SaleCommon Stock | 1,380 | $20.92 | $28,869.60 |
DisclosureSEC source: 0001192482-20-000348 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,670 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2019. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.87 to $20.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:15 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 4,434 | $22.61 | $100,252.74 |
DisclosureSEC source: 0001192482-20-000346 · edgar.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,441 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019 and modified on March 5, 2020. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:16 UTC |
Malamut RichardEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 2,920 | $15.49 | $45,230.80 |
DisclosureSEC source: 0001192482-20-000272 · edgar.xml · nonDerivative · entry 1 Malamut Richard · CIK 0001772168 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,830 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 16:16 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
Tax withholdingCommon Stock | 734 | $15.41 | $11,310.94 |
DisclosureSEC source: 0001192482-20-000240 · edgar.xml · nonDerivative · entry 1 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,325 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 16:25 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
Tax withholdingCommon Stock | 2,085 | $21.62 | $45,077.70 |
DisclosureSEC source: 0001192482-20-000149 · edgar.xml · nonDerivative · entry 1 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,059 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:22 UTC |
Heffernan Michael ThomasDirector
|
Tax withholdingCommon Stock | 4,962 | $21.62 | $107,278.44 |
DisclosureSEC source: 0001192482-20-000148 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,050 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 16:28 UTC |
Fleming Alison BChief Technology Officer
|
Tax withholdingCommon Stock | 3,568 | $21.62 | $77,140.16 |
DisclosureSEC source: 0001192482-20-000151 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,890 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:30 UTC |
Ciaffoni JosephDirector · President and CEO
|
Tax withholdingCommon Stock | 7,499 | $21.62 | $162,128.38 |
DisclosureSEC source: 0001192482-20-000152 · edgar.xml · nonDerivative · entry 1 Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,187 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:32 UTC |
Brannelly PaulExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 4,025 | $21.62 | $87,020.50 |
DisclosureSEC source: 0001192482-20-000153 · edgar.xml · nonDerivative · entry 1 Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,273 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,966 | $21.62 | $42,504.92 |
DisclosureSEC source: 0001192482-20-000150 · edgar.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,875 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:11 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
GrantStock Option (Right to Purchase) · Derivative | 27,500 | $0.00 Strike: $21.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000138 · edgar.xml · derivative · entry 2 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2030-02-05 F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:11 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
GrantCommon Stock | 24,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000138 · edgar.xml · nonDerivative · entry 1 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,144 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:41 UTC |
Fleming Alison BChief Technology Officer
|
GrantStock Option (Right to Purchase) · Derivative | 25,000 | $0.00 Strike: $21.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000140 · edgar.xml · derivative · entry 3 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-02-05 F3 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:41 UTC |
Fleming Alison BChief Technology Officer
|
GrantCommon Stock | 18,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000140 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,458 F2 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 1, 2021, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on the vesting date in shares of the issuer's common stock. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 16:41 UTC |
Fleming Alison BChief Technology Officer
|
GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000140 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,842 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:08 UTC |
Ciaffoni JosephDirector · President and CEO
|
GrantStock Option (Right to Purchase) · Derivative | 90,000 | $0.00 Strike: $21.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000135 · edgar.xml · derivative · entry 2 Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2030-02-05 F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:08 UTC |
Ciaffoni JosephDirector · President and CEO
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000135 · edgar.xml · nonDerivative · entry 1 Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,686 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:11 UTC |
Malamut RichardEVP and Chief Medical Officer
|
GrantStock Option (Right to Purchase) · Derivative | 22,500 | $0.00 Strike: $21.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000139 · edgar.xml · derivative · entry 2 Malamut Richard · CIK 0001772168 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2030-02-05 F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:11 UTC |
Malamut RichardEVP and Chief Medical Officer
|
GrantCommon Stock | 20,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000139 · edgar.xml · nonDerivative · entry 1 Malamut Richard · CIK 0001772168 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,750 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:10 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
GrantStock Option (Right to Purchase) · Derivative | 21,250 | $0.00 Strike: $21.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000137 · edgar.xml · derivative · entry 2 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,250 Underlying: Common Stock · 21,250 shares Expires 2030-02-05 F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:10 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
GrantCommon Stock | 19,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000137 · edgar.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,841 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:09 UTC |
Brannelly PaulExecutive Vice President & CFO
|
GrantStock Option (Right to Purchase) · Derivative | 31,250 | $0.00 Strike: $21.34 | $0.00 |
DisclosureSEC source: 0001192482-20-000136 · edgar.xml · derivative · entry 2 Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 31,250 shares Expires 2030-02-05 F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:09 UTC |
Brannelly PaulExecutive Vice President & CFO
|
GrantCommon Stock | 28,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000136 · edgar.xml · nonDerivative · entry 1 Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,298 F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 16:27 UTC |
Fleming Alison BChief Technology Officer
|
Tax withholdingCommon Stock | 214 | $21.56 | $4,613.84 |
DisclosureSEC source: 0001192482-20-000044 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,342 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 21:29 UTC |
Heffernan Michael ThomasDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 275,463 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0001192482-20-000046 · edgar.xml · derivative · entry 5 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 275,463 shares Expires 2025-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All of the 275,463 option shares are exercisable. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 21:29 UTC |
Heffernan Michael ThomasDirector
|
Tax withholdingCommon Stock | 787 | $21.56 | $16,967.72 |
DisclosureSEC source: 0001192482-20-000046 · edgar.xml · nonDerivative · entry 4 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,012 F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 21:29 UTC |
Heffernan Michael ThomasDirector
|
SaleCommon Stock | 32,700 | $22.69 | $741,963.00 |
DisclosureSEC source: 0001192482-20-000046 · edgar.xml · nonDerivative · entry 3 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,799 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2019. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.42 to $23.30, inclusive. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 21:29 UTC |
Heffernan Michael ThomasDirector
|
SaleCommon Stock | 262,587 | $21.84 | $5,734,900.08 |
DisclosureSEC source: 0001192482-20-000046 · edgar.xml · nonDerivative · entry 2 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,499 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2019. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.42 to $22.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 21:29 UTC |
Heffernan Michael ThomasDirector
|
Exercise / conversionCommon Stock | 275,463 | $5.73 | $1,578,402.99 |
DisclosureSEC source: 0001192482-20-000046 · edgar.xml · nonDerivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 21:26 UTC |
Brannelly PaulExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 214 | $21.56 | $4,613.84 |
DisclosureSEC source: 0001192482-20-000042 · edgar.xml · nonDerivative · entry 1 Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,173 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 21:12 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
SaleCommon Stock | 1,321 | $23.87 | $31,532.27 |
DisclosureSEC source: 0001192482-20-000038 · edgar.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,716 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2019. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:27 UTC |
Dreyer ScottEVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 702 | $23.30 | $16,356.60 |
DisclosureSEC source: 0001192482-20-000036 · edgar.xml · nonDerivative · entry 1 Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,037 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:07 UTC |
Ciaffoni JosephDirector · President and CEO
|
Tax withholdingCommon Stock | 1,091 | $20.58 | $22,452.78 |
DisclosureSEC source: 0001192482-20-000002 · edgar.xml · nonDerivative · entry 1 Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,686 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 22:26 UTC |
Freund John GordonDirector
|
OtherCommon Stock | 8,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000463 · edgar.xml · nonDerivative · entry 2 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Skyline Venture Management V LLC Disclosed balance after: 8,625 F3 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to Dr. Freund. F4 · ownership.nature: The shares are held by Skyline Venture Management V, LLC. See footnote (2). Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 22:26 UTC |
Freund John GordonDirector
|
OtherCommon Stock | 574,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000463 · edgar.xml · nonDerivative · entry 1 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Skyline Venture Partners V, L.P. Disclosed balance after: 0 F1 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to its limited and general partners. F2 · ownership.nature: The shares were held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC. Dr. Freund disclaims beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 21:16 UTC |
Ciaffoni JosephDirector · President and CEO
|
Tax withholdingCommon Stock | 4,678 | $21.73 | $101,652.94 |
DisclosureSEC source: 0001192482-19-000451 · edgar.xml · nonDerivative · entry 1 Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,777 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 21:12 UTC |
Freund John GordonDirector
|
OtherCommon Stock | 8,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000438 · edgar.xml · nonDerivative · entry 2 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: John Freund Family Partnership IV, L.P. Disclosed balance after: 34,788 F3 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to the reporting person. F4 · ownership.nature: The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 21:12 UTC |
Freund John GordonDirector
|
OtherCommon Stock | 575,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000438 · edgar.xml · nonDerivative · entry 1 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Skyline Venture Partners V, L.P. Disclosed balance after: 574,916 F1 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to its limited and general partners. F2 · ownership.nature: The shares are held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC. Dr. Freund disclaims beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 16:32 UTC |
Fleming Alison BChief Technology Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 25,000 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0001192482-19-000405 · edgar.xml · derivative · entry 3 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,378 Underlying: Common Stock · 25,000 shares Expires 2025-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was fully vested and exercisable as of November 8, 2019. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 16:32 UTC |
Fleming Alison BChief Technology Officer
|
SaleCommon Stock | 25,000 | $19.44 | $486,000.00 |
DisclosureSEC source: 0001192482-19-000405 · edgar.xml · nonDerivative · entry 2 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,556 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.71, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 16:32 UTC |
Fleming Alison BChief Technology Officer
|
Exercise / conversionCommon Stock | 25,000 | $5.73 | $143,250.00 |
DisclosureSEC source: 0001192482-19-000405 · edgar.xml · nonDerivative · entry 1 Fleming Alison B · CIK 0001640701 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 21:33 UTC |
Hirsch DavidDirector
|
SaleCommon Stock | 25,000 | $19.33 | $483,250.00 |
DisclosureSEC source: 0001192482-19-000406 · edgar.xml · nonDerivative · entry 1 Hirsch David · CIK 0001619884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,117 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.66, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 21:11 UTC |
Ciaffoni JosephDirector · President and CEO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 64,821 | $0.00 Strike: $8.22 | $0.00 |
DisclosureSEC source: 0001192482-19-000392 · edgar.xml · derivative · entry 4 Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,641 Underlying: Common Stock · 64,821 shares Expires 2027-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 81,026 shares under the option are exercisable. The option, initially representing a right to purchase a total of 259,283 shares, vests and becomes exercisable over a four-year period commencing on May 31, 2017. Twenty-five percent (25%) of the option vested and became exercisable on May 31, 2018 and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) at the end of each quarterly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the Issuer. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 21:11 UTC |
Ciaffoni JosephDirector · President and CEO
|
SaleCommon Stock | 31,226 | $19.16 | $598,290.16 |
DisclosureSEC source: 0001192482-19-000392 · edgar.xml · nonDerivative · entry 3 Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,455 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 21:11 UTC |
Ciaffoni JosephDirector · President and CEO
|
SaleCommon Stock | 33,595 | $18.41 | $618,483.95 |
DisclosureSEC source: 0001192482-19-000392 · edgar.xml · nonDerivative · entry 2 Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,681 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.13 to $18.53, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 21:11 UTC |
Ciaffoni JosephDirector · President and CEO
|
Exercise / conversionCommon Stock | 64,821 | $8.22 | $532,828.62 |
DisclosureSEC source: 0001192482-19-000392 · edgar.xml · nonDerivative · entry 1 Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 16:06 UTC |
Kuhlmann Shirley R.EVP and General Counsel
|
Tax withholdingCommon Stock | 736 | $12.44 | $9,155.84 |
DisclosureSEC source: 0001192482-19-000360 · edgar.xml · nonDerivative · entry 1 Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,394 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 22:16 UTC |
Hirsch DavidDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 19,853 | $0.00 Strike: $9.33 | $0.00 |
DisclosureSEC source: 0001192482-19-000352 · edgar.xml · derivative · entry 3 Hirsch David · CIK 0001619884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,853 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.